FindMyKOL
Clinical trialNCT05582447Active, not recruitingObservational

Osmotic Fragility in Red Blood Cells of Pediatric Patients With Cholestatic Liver Disease

NCT05582447 is an observational study sponsored by Children's Hospital Medical Center, Cincinnati. As of 21 Nov 2026, it is active and no longer recruiting. It studies Cholestasis and Red Cell Membrane and Enzyme Abnormalities. The registry lists an enrollment of 40 participants at 1 site in 1 country. The registry lists a start date of 17 Apr 2018 and a primary completion date of 31 Dec 2026.

SponsorChildren's Hospital Medical Center, CincinnatiEnrollment40CholestasisRed Cell Membrane and Enzyme Abnormalities
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT05582447
FieldValue
Registry IDNCT05582447
StatusActive not recruiting
Study typeObservational study
Lead sponsorChildren's Hospital Medical Center, Cincinnati
Enrollment40
Registered sites1
Countries1
ConditionsCholestasis and Red Cell Membrane and Enzyme Abnormalities
Start17 Apr 2018
Primary completion31 Dec 2026
Study completion31 Dec 2027
Last update posted6 Feb 2026

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Objective: The investigators propose to perform ektacytometry on 20 pediatric patients over age one with cholestatic liver diseases and a direct bilirubin level of greater than 2 gm/dl. The most common diagnoses will be extrahepatic biliary atresia, progressive familial intrahepatic cholestasis, Alagille syndrome, autoimmune hepatitis, primary sclerosing cholangitis, and parenteral nutrition-associated cholestasis. The investigators will correlate the osmotic fragility and deformability with direct bilirubin levels, serum cholesterol levels, serum bile acid levels, and vitamin E levels. Design/Methods: This pilot study will be a single center, prospective cross-sectional investigation of red blood cell ektacytometry in pediatric patients with extrahepatic cholestasis who are followed at Cincinnati Children's Hospital Medical Center. The study will include all participants with cholestasis regardless of the etiology in order to maximize the number of participants. While the population will be heterogeneous, the investigators will stratify participants according to diagnosis, recognizing that only a few participants may fall into each diagnostic category. Ektacytometry will be the method utilized to measure osmotic fragility and deformability of the RBC membrane. The ektacytometry of red cells from cholestatic patients will be compared to that of red cells obtained from contemporaneous age-matched controls recruited among patients without liver disease or red cell membrane defects undergoing blood sampling for evaluation of other entities including but not confined to functional abdominal pain.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

  • Samuel A Kocoshis, MD

    Children's Hospital Medical Center, Cincinnati

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Ohio, United States1 site
  • Cincinnati Children's Hospital Medical Center

    Cincinnati

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhio: 1 siteOH1PennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT05582447

Each answer restates registry values shown on this page.

What is NCT05582447?

NCT05582447 is an observational study sponsored by Children's Hospital Medical Center, Cincinnati. It studies Cholestasis and Red Cell Membrane and Enzyme Abnormalities.

Is NCT05582447 recruiting?

As of 21 Nov 2026, it is active and no longer recruiting.

Who leads NCT05582447?

The registry names Samuel A Kocoshis, MD (principal investigator, Children's Hospital Medical Center, Cincinnati) as the overall official.

Where does NCT05582447 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When is NCT05582447 expected to complete?

The registry lists a primary completion date of 31 Dec 2026 and a study completion date of 31 Dec 2027. The sponsor last updated the record on 6 Feb 2026.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.